Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Tolvaptan

An oral vasopressin V2 receptor antagonist, blocking the antidiuretic hormone: it helps the kidneys get rid of excess water and was approved in the US in 2009 for hyponatraemia, meaning too little sodium in the blood. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?In 2014 Japan approved it as the world's first drug treatment to slow autosomal dominant polycystic kidney disease.

TolvaptanGo to the active ingredient →
TolvaptanActive ingredientTolvaptanCat. No. P-T160-001CAS 150683-30-0
Tolvaptan-d7Isotopically labelledTolvaptan-d7Cat. No. P-T160-003CAS 1246818-18-7

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.